Infectious Diseases Program, Biology Department, Queensland Institute of Medical Research, Brisbane, Queensland, Australia.
PLoS One. 2012;7(7):e40489. doi: 10.1371/journal.pone.0040489. Epub 2012 Jul 11.
Scabies is a parasitic infestation of the skin by the mite Sarcoptes scabiei that causes significant morbidity worldwide, in particular within socially disadvantaged populations. In order to identify mechanisms that enable the scabies mite to evade human immune defenses, we have studied molecules associated with proteolytic systems in the mite, including two novel scabies mite serine protease inhibitors (SMSs) of the serpin superfamily. Immunohistochemical studies revealed that within mite-infected human skin SMSB4 (54 kDa) and SMSB3 (47 kDa) were both localized in the mite gut and feces. Recombinant purified SMSB3 and SMSB4 did not inhibit mite serine and cysteine proteases, but did inhibit mammalian serine proteases, such as chymotrypsin, albeit inefficiently. Detailed functional analysis revealed that both serpins interfered with all three pathways of the human complement system at different stages of their activation. SMSB4 inhibited mostly the initial and progressing steps of the cascades, while SMSB3 showed the strongest effects at the C9 level in the terminal pathway. Additive effects of both serpins were shown at the C9 level in the lectin pathway. Both SMSs were able to interfere with complement factors without protease function. A range of binding assays showed direct binding between SMSB4 and seven complement proteins (C1, properdin, MBL, C4, C3, C6 and C8), while significant binding of SMSB3 occurred exclusively to complement factors without protease function (C4, C3, C8). Direct binding was observed between SMSB4 and the complement proteases C1s and C1r. However no complex formation was observed between either mite serpin and the complement serine proteases C1r, C1s, MASP-1, MASP-2 and MASP-3. No catalytic inhibition by either serpin was observed for any of these enzymes. In summary, the SMSs were acting at several levels mediating overall inhibition of the complement system and thus we propose that they may protect scabies mites from complement-mediated gut damage.
疥疮是一种由疥螨寄生在皮肤引起的寄生虫感染,在全球范围内导致了相当高的发病率,特别是在社会弱势群体中。为了确定使疥螨逃避人类免疫防御的机制,我们研究了与螨体内蛋白水解系统相关的分子,包括两种新的疥疮螨丝氨酸蛋白酶抑制剂(SMSs)的丝氨酸蛋白酶抑制剂超家族。免疫组织化学研究表明,在感染的螨虫皮肤中,SMSB4(54 kDa)和 SMSB3(47 kDa)均定位于螨虫肠道和粪便中。重组纯化的 SMSB3 和 SMSB4 不能抑制螨虫丝氨酸和半胱氨酸蛋白酶,但能抑制哺乳动物丝氨酸蛋白酶,如糜蛋白酶,但效率不高。详细的功能分析表明,这两种丝氨酸蛋白酶抑制剂在其激活的不同阶段干扰了人类补体系统的三条途径。SMSB4 主要抑制级联反应的初始和进展阶段,而 SMSB3 在补体系统的终末途径的 C9 水平上显示出最强的作用。在补体系统的凝集素途径中,两种丝氨酸蛋白酶抑制剂在 C9 水平上表现出相加作用。这两种 SMSs 都能够在没有蛋白酶功能的情况下干扰补体因子。一系列结合测定表明,SMSB4 与七种补体蛋白(C1、备解素、MBL、C4、C3、C6 和 C8)之间存在直接结合,而 SMSB3 与没有蛋白酶功能的补体因子(C4、C3、C8)之间则存在显著结合。在 SMSB4 与补体蛋白酶 C1s 和 C1r 之间观察到直接结合。然而,在任何一种丝氨酸蛋白酶抑制剂与补体丝氨酸蛋白酶 C1r、C1s、MASp-1、MASp-2 和 MASp-3 之间都没有观察到复合物的形成。这两种丝氨酸蛋白酶抑制剂对这些酶都没有催化抑制作用。总之,SMSs 在多个水平上发挥作用,介导补体系统的整体抑制,因此我们提出它们可能保护疥螨免受补体介导的肠道损伤。